Publications by authors named "C Geiger"
Background: Pneumocystis jirovecii pneumonia (PCP) is a serious opportunistic infection in people living with HIV (PWH) who have low CD4 counts. Despite its side effects, trimethoprim-sulfamethoxazole (TMP-SMX) is currently considered the primary treatment for PCP.
Objectives: To compare the efficacy (treatment-failure and mortality) and tolerability (treatment change) of PCP treatment-regimens with a frequentist network meta-analysis (NMA).
Article Synopsis
- Invasive pulmonary aspergillosis (IPA) is increasingly affecting critically ill ICU patients who lack traditional risk factors, complicating diagnosis due to histological evidence challenges.
- A study analyzed 202 patients across nine centers, comparing existing classification criteria (EORTC-MSG, FUNDICU, Asp-ICU) for diagnosing IPA and their effectiveness in identifying cases confirmed by histology.
- Findings revealed that EORTC-MSG was highly effective in patients with known risk factors, while the FUNDICU criteria's accuracy improved when including factors like ARDS and post-cardiac surgery complications, enhancing its predictive performance.
Surface sensing is a key aspect of the early stage of biofilm formation. For , the type IV pili (TFP), the TFP alignment complex and PilY1 were shown to play a key role in c-di-GMP signaling upon surface contact. The role of the flagellar machinery in surface sensing is less well understood in .
View Article and Find Full Text PDFObjective: "Brain fog" is a frequently reported, distressing experience among individuals with chronic hypoparathyroidism, characterized by reduced concentration and reduced ability to perform day-to-day tasks. However, evidence linking chronic hypoparathyroidism to cognitive impairment is limited and inconsistent. This study aimed to explore cognitive function in these patients using a validated neurocognitive test battery, compare results with a matched healthy control group, and analyze the frequency of cognitive impairment based on normative data.
View Article and Find Full Text PDFPurpose: Abiraterone use for prostate cancer can cause mineralocorticoid excess syndrome (MES; eg, hypertension and hypokalemia). Prednisone mitigates these effects; however, the optimal dose level is unclear. This study examines MES effects from abiraterone with 5 mg of prednisone once daily versus 5 mg twice daily.
View Article and Find Full Text PDF